Patents by Inventor Juha Yrjänheikki

Juha Yrjänheikki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chloride-Inducible Prokaryotic Expression System
    Publication number: 20220127629
    Abstract: The invention is directed to recombinant bacteria, a recombinant plasmid, a pharmaceutical composition and a kit as well as the use of a reconstitution medium comprising chloride ions to reconstitute the recombinant bacteria.
    Type: Application
    Filed: March 4, 2019
    Publication date: April 28, 2022
    Inventors: Thomas Wirth, Juha Yrjänheikki, Haritha Samaranayake, Hanna-Riikka Kärkkäinen, Jere Kurkipuro, Igor Mierau, Wesley Smith
  • Recombinant probiotic bacteria
    Patent number: 10738315
    Abstract: The invention is directed to recombinant probiotic bacteria, especially for use in the treatment of an inflammatory skin dysfunction, as well as a method for treating an inflammatory skin dysfunction.
    Type: Grant
    Filed: November 2, 2015
    Date of Patent: August 11, 2020
    Assignee: Aurealis Oy
    Inventors: Thomas Wirth, Juha Yrjänheikki, Haritha Samaranayake, Dirk Weber, Igor Mierau, Peter Allard Bron, Herwig Bachmann
  • Recombinant Probiotic Bacteria
    Publication number: 20180135062
    Abstract: The invention is directed to recombinant probiotic bacteria, especially for use in the treatment of an inflammatory skin dysfunction, as well as a method for treating an inflammatory skin dysfunction.
    Type: Application
    Filed: November 2, 2015
    Publication date: May 17, 2018
    Inventors: Thomas Wirth, Juha Yrjänheikki, Haritha Samaranayake, Dirk Weber, Igor Mierau, Peter Allard Bron, Herwig Bachmann
  • Systemic and/or local (topical) application of tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases, traumas and damages of nervous system
    Patent number: 6277393
    Abstract: A method for treating and/or preventing of cerebrovascular diseases, traumas and damages of the nervous system, which method includes local (topical) and/or systemic application of an effective amount of tetracycline and/or tetracycline derivative or a mixture of tetracycline and/or tetracycline derivative(s) (“active agent(s)”), optionally in a pharmaceutically-acceptable diluent, carrier or release system (“active compostition”).
    Type: Grant
    Filed: December 10, 1999
    Date of Patent: August 21, 2001
    Assignee: Bioabsorbable Concepts, Inc.
    Inventors: Juha Yrjänheikki, Pertti Törmäl{umlaut over (a )}, Riitta Keinänen, Nina Vartiainen, Susanna Miettinen, Auvo Kaikkonen, Jari Koistinaho